vs

Side-by-side financial comparison of AST SpaceMobile, Inc. (ASTS) and Beauty Health Co (SKIN). Click either name above to swap in a different company.

Beauty Health Co is the larger business by last-quarter revenue ($82.4M vs $54.3M, roughly 1.5× AST SpaceMobile, Inc.). Over the past eight quarters, AST SpaceMobile, Inc.'s revenue compounded faster (173.4% CAGR vs 0.6%).

AST SpaceMobile, Inc. is a publicly traded satellite designer and manufacturer based in Midland, Texas, United States. The company is building the SpaceMobile satellite constellation, a space-based cellular broadband network designed to connect directly to standard, unmodified smartphones. The network is intended to deliver 4G and 5G broadband coverage globally, particularly in remote and underserved regions.

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

ASTS vs SKIN — Head-to-Head

Bigger by revenue
SKIN
SKIN
1.5× larger
SKIN
$82.4M
$54.3M
ASTS
Faster 2-yr revenue CAGR
ASTS
ASTS
Annualised
ASTS
173.4%
0.6%
SKIN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASTS
ASTS
SKIN
SKIN
Revenue
$54.3M
$82.4M
Net Profit
$-8.1M
Gross Margin
64.4%
Operating Margin
-560.4%
0.2%
Net Margin
-9.8%
Revenue YoY
-1.3%
Net Profit YoY
21.5%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTS
ASTS
SKIN
SKIN
Q1 26
$54.3M
Q4 25
$54.3M
$82.4M
Q3 25
$14.7M
$70.7M
Q2 25
$78.2M
Q1 25
$69.6M
Q4 24
$83.5M
Q3 24
$78.8M
Q2 24
$90.6M
Net Profit
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
$-74.0M
$-8.1M
Q3 25
$-122.9M
$-11.0M
Q2 25
$19.7M
Q1 25
$-10.1M
Q4 24
$-10.3M
Q3 24
$-18.3M
Q2 24
$202.0K
Gross Margin
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
64.4%
Q3 25
64.6%
Q2 25
62.8%
Q1 25
69.8%
Q4 24
62.7%
Q3 24
51.6%
Q2 24
45.2%
Operating Margin
ASTS
ASTS
SKIN
SKIN
Q1 26
-560.4%
Q4 25
-175.0%
0.2%
Q3 25
-1109.0%
-8.8%
Q2 25
-3.5%
Q1 25
-17.3%
Q4 24
-8.6%
Q3 24
-27.3%
Q2 24
-24.4%
Net Margin
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
-136.2%
-9.8%
Q3 25
-833.7%
-15.6%
Q2 25
25.2%
Q1 25
-14.5%
Q4 24
-12.4%
Q3 24
-23.2%
Q2 24
0.2%
EPS (diluted)
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
$-0.02
Q3 25
$-0.09
Q2 25
$0.03
Q1 25
$-0.08
Q4 24
$-0.01
Q3 24
$-0.15
Q2 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTS
ASTS
SKIN
SKIN
Cash + ST InvestmentsLiquidity on hand
$2.3B
Total DebtLower is stronger
$12.0M
Stockholders' EquityBook value
$2.4B
$61.1M
Total Assets
$5.0B
$499.8M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTS
ASTS
SKIN
SKIN
Q1 26
$2.3B
Q4 25
$4.3B
Q3 25
$2.4B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Total Debt
ASTS
ASTS
SKIN
SKIN
Q1 26
$12.0M
Q4 25
Q3 25
$363.4M
Q2 25
$363.1M
Q1 25
Q4 24
$552.2M
Q3 24
Q2 24
Stockholders' Equity
ASTS
ASTS
SKIN
SKIN
Q1 26
$2.4B
Q4 25
$2.4B
$61.1M
Q3 25
$1.6B
$65.7M
Q2 25
$74.0M
Q1 25
$46.1M
Q4 24
$51.8M
Q3 24
$59.7M
Q2 24
$69.2M
Total Assets
ASTS
ASTS
SKIN
SKIN
Q1 26
$5.0B
Q4 25
$5.0B
$499.8M
Q3 25
$2.6B
$503.6M
Q2 25
$507.6M
Q1 25
$673.8M
Q4 24
$685.7M
Q3 24
$699.5M
Q2 24
$711.8M
Debt / Equity
ASTS
ASTS
SKIN
SKIN
Q1 26
0.01×
Q4 25
Q3 25
5.53×
Q2 25
4.91×
Q1 25
Q4 24
10.66×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTS
ASTS
SKIN
SKIN
Operating Cash FlowLast quarter
$15.2M
Free Cash FlowOCF − Capex
$15.1M
FCF MarginFCF / Revenue
18.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
$65.0M
$15.2M
Q3 25
$-64.5M
$9.6M
Q2 25
$9.6M
Q1 25
$3.0M
Q4 24
$16.5M
Q3 24
$10.3M
Q2 24
$6.2M
Free Cash Flow
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
$-330.7M
$15.1M
Q3 25
$-302.9M
$9.6M
Q2 25
$9.6M
Q1 25
$3.0M
Q4 24
$16.4M
Q3 24
$10.3M
Q2 24
$5.9M
FCF Margin
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
-609.0%
18.3%
Q3 25
-2055.0%
13.6%
Q2 25
12.2%
Q1 25
4.2%
Q4 24
19.6%
Q3 24
13.1%
Q2 24
6.5%
Capex Intensity
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
728.7%
0.2%
Q3 25
1617.6%
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.4%
Cash Conversion
ASTS
ASTS
SKIN
SKIN
Q1 26
Q4 25
Q3 25
Q2 25
0.49×
Q1 25
Q4 24
Q3 24
Q2 24
30.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTS
ASTS

Segment breakdown not available.

SKIN
SKIN

Consumables$57.7M70%
Delivery Systems$24.7M30%

Related Comparisons